This inventor holds 1 USPTO granted patent. Top assignees: National Yang Ming Chiao Tung University, Taipei Veterans General Hospital. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Shih-Yu Fang: Innovator in Alzheimer's Disease Risk Assessment
Introduction
Shih-Yu Fang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of cognitive health, particularly in the early detection of Alzheimer's disease. His innovative approach combines advanced imaging techniques with risk assessment models to provide valuable insights into cognitive impairment.
Latest Patents
Shih-Yu Fang holds a patent titled "Method for determining probability of subject with mild cognition impairment developing Alzheimer's disease within predetermined time period." This method is designed to be implemented by a computing device that stores a risk assessment model. The process involves obtaining target physiological data and magnetic resonance imaging (MRI) images of a subject's brain. It includes steps such as calculating voxel values related to grey matter and determining the probability of developing Alzheimer's disease based on these values.
Career Highlights
Throughout his career, Shih-Yu Fang has worked with esteemed institutions such as National Yang Ming Chiao Tung University and Taipei Veterans General Hospital. His work has focused on enhancing the understanding of cognitive impairments and developing methods to assess the risk of Alzheimer's disease.
Collaborations
Shih-Yu Fang has collaborated with notable colleagues, including Jong-Ling Fuh and Albert Chihchieh Yang. These collaborations have contributed to the advancement of research in cognitive health and the development of innovative assessment methods.
Conclusion
Shih-Yu Fang's contributions to the field of cognitive health through his patent and collaborative efforts highlight his commitment to improving early detection methods for Alzheimer's disease. His work continues to pave the way for advancements in understanding and managing cognitive impairments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile